Precision medicine is revolutionizing the clinical practice. With the advent of molecular technologies, medical professional are slowly gaining the ability to provide customized diagnostics, tailored therapies to maximize efficacy and minimize side effects and even delay the onset of diseases in a range of clinical applications (Cancer, neurodegenerative diseases etc
Relatively new technology in the researchers’ arsenal is quantitative proteomics. Quantitative proteomics refers to quantifying the abundance of the various “building blocks of life” (proteins) in biological tissues or specimens. For example in clinical practice, by using quantitative proteomics to study the complete protein profile of an individual, researchers can estimate the overabundant and deficient proteins on a given sample of an individual. The ability to acquire this information at the individual level in an affordable and reproducible manner paves the way towards novel clinical applications in personalized diagnostics, stratified therapies and more.
In a recent review article, “Towards Building a Quantitative Proteomics Toolbox in Precision Medicine: A Mini-Review”, published in the journal Frontiers in Physiology, researchers from the Flemish Institute for Technological Research (VITO) led by Dr. Gokhan Ertaylan and the University of Hasselt led by Dr. Dirk Valkenborg, describe the current status of the technological advances in quantitative proteomics for precision medicine, identify the main challenges and highlight potential future applications in the horizon.
We are happy to announce our recent paper “Towards Building a Quantitative Proteomics Toolbox in Precision Medicine: A Mini-Review”, published in the journal Frontiers in Physiology. Here we describe quantitative proteomics and its potential impact in the field of Precision Medicine. We argue that the ability to acquire this information at the personal level in an affordable, standardized and reproducible manner could pave the way towards novel clinical applications in personalized diagnostics, stratified therapies and more.
More info
Désirée De Poot (press VITO): 0475/45.70.10 desiree.depoot@vito.be
Gokhan Ertaylan (VITO): gokhan.ertaylan@vito.be
Dirk Valkenborg (UHasselt): dirk.valkenborg@uhasselt.be
